| 发明名称 |
ANTIDIABETIC MEDICATIONS COMPRISING A DPP-4 INHIBITOR (LINAGLIPTIN) OPTIONALLY IN COMBINATION WITH OTHER ANTIDIABETICS |
| 摘要 |
The invention relates to antidiabetic medications which are suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia, inter alia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions. The medication is a mono treatment with a DPP-4 inhibitor <preferably linagliptin> or a combination treatment with a DPP-4 inhibitor and a second and/or third antidiabetic.
|
| 申请公布号 |
US2012094894(A1) |
申请公布日期 |
2012.04.19 |
| 申请号 |
US201013148065 |
申请日期 |
2010.02.12 |
| 申请人 |
GRAEFE-MODY EVA ULRIKE;WOERLE HANS-JUERGEN;BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
发明人 |
GRAEFE-MODY EVA ULRIKE;WOERLE HANS-JUERGEN |
| 分类号 |
A61K31/522;A61K38/26;A61P1/16;A61P3/00;A61P3/04;A61P3/10;A61P9/00;A61P9/04;A61P9/10;A61P13/12;A61P25/00;A61P25/28;A61P27/02;A61P27/12 |
主分类号 |
A61K31/522 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
